K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons

Nature Neuroscience

Volumn 8, Issue 12, 2005, Pages 1742-1751

  Liss, Birgit ^a,b,c   Haeckel, Olga ^a   Wildmann, Johannes ^a   Miki, Takashi ^d   Seino, Susumu ^d   Roeper, Jochen ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE TRIPHOSPHATE; DOPAMINE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; POTASSIUM; TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CELL ACTIVITY; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; DISABILITY; DOPAMINERGIC NERVE CELL; ELECTROPHYSIOLOGY; GENE INACTIVATION; MALE; MESENCEPHALON; MOUSE; MOUSE MUTANT; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSONISM; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; DRUG RESISTANCE; ELECTRON TRANSPORT COMPLEX I; FEMALE; GENETIC PREDISPOSITION TO DISEASE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NEUROLOGIC MUTANTS; NERVE DEGENERATION; NEURONS; NEUROTOXINS; ORGAN CULTURE TECHNIQUES; OXIDATIVE STRESS; PARKINSON DISEASE; PARKINSONIAN DISORDERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA;

EID: 28044469874     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1570     Document Type: Article

References (49)

1. Morrison, B.M., Hof, P.R. & Morrison, J.H. Determinants of neuronal vulnerability in neurodegenerative diseases. Ann. Neurol. 44, S32-S44 (1998).
2. Damier, P., Hirsch, E.C., Agid, Y. & Graybiel, A.M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122, 1437-1448 (1999).
3. Greenamyre, J.T. & Hastings, T.G. Biomedicine. Parkinson's-divergent causes, convergent mechanisms. Science 304, 1120-1122 (2004).
4. Moore, D.J., West, A.B., Dawson, V.L. & Dawson, T.M. Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28, 57-87 (2005).
5. Dauer, W. & Przedborski, S. Parkinson's disease: mechanisms and models. Neuron 39, 889-909 (2003).
6. Schapira, A.H. Causes of neuronal death in Parkinson's disease. Adv. Neurol. 86, 155-162 (2001).
7. Moratalla, R. et al. Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 89, 3859-3863 (1992).
8. Petroske, E., Meredith, G.E., Callen, S., Totterdell, S. & Lau, Y.S. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment. Neuroscience 106, 589-601 (2001).
9. Greene, J.G., Dingledine, R. & Greenamyre, J.T. Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism. Neurobiol. Dis. 18, 19-31 (2005).
10. Betarbet, R. et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306 (2000).
11. Przedborski, S. & Vila, M. The 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease. Ann. NY Acad. Sci. 991, 189-198 (2003).
12. Langston, J.W. The etiology of Parkinson's disease with emphasis on the MPTP story. Neurology 47, S153-S160 (1996).
13. Hoglinger, G.U. et al. Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease. J. Neurochem. 86, 1297-1307 (2003).
14. Testa, C.M., Sherer, T.B. & Greenamyre, J.T. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. Brain Res. Mol. Brain Res. 134, 109-118 (2005).
15. Seino, S. & Miki, T. Gene targeting approach to clarification of ion channel function: studies of Kir6.x null mice. J. Physiol. (Lond.) 554, 295-300 (2004).
16. + channels. Diabetes 53, S104-S112 (2004).
17. Ashcroft, F. & Rorsman, P. Type 2 diabetes mellitus: not quite exciting enough? Hum. Mol. Genet. 13, R21-R31 (2004).
18. Liss, B., Bruns, R. & Roeper, J. Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons. EMBO J. 18, 833-846 (1999).
19. Liu, Y. & Gutterman, D.D. Oxidative stress and potassium channel function. Clin. Exp. Pharmacol. Physiol. 29, 305-311 (2002).
20. Avshalumov, M.V., Chen, B.T., Koos, T., Tepper, J.M. & Rice, M.E. Endogenous hydrogen peroxide regulates the excitability of midbrain dopamine neurons via atp-sensitive potassium channels. J. Neurosci. 25, 4222-4231 (2005).
21. Liss, B. & Roeper, J. Correlating function and gene expression of individual basal ganglia neurons. Trends Neurosci. 27, 475-481 (2004).
22. Neuhoff, H., Neu, A., Liss, B. & Roeper, J.I. (h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J. Neurosci. 22, 1290-1302 (2002).
23. + channel in substantia nigra neurons. J. Neurosci. 14, 5590-5602 (1994).
24. Mercuri, N.B. et al. Effects of anoxia on rat midbrain dopamine neurons. J. Neurophysiol. 71, 1165-1173 (1994).
25. Liss, B., Neu, A. & Roeper, J. The weaver mouse gain-of-function phenotype of dopaminergic midbrain neurons is determined by coactivation of wvGirk2 and K-ATP channels. J. Neurosci. 19, 8839-8848 (1999).
26. Miki, T. et al. Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc. Natl. Acad. Sci. USA 95, 10402-10406 (1998).
27. + channel: a pas de deux. Diabetes 53, S113-S122 (2004).
28. Lin, Y.F., Raab-Graham, K., Jan, Y.N. & Jan, L.Y. NO stimulation of ATP-sensitive potassium channels: involvement of Ras/mitogen-activated protein kinase pathway and contribution to neuroprotection. Proc. Natl. Acad. Sci. USA 101, 7799-7804 (2004).
29. Lin, Y.F., Jan, Y.N. & Jan, L.Y. Regulation of ATP-sensitive potassium channel function by protein kinase A-mediated phosphorylation in transfected HEK293 cells. EMBO J. 19, 942-955 (2000).
30. Baukrowitz, T. et al. PIP2 and PIP as determinants for ATP inhibition of KATP channels. Science 282, 1141-1144 (1998).
31. Krauss, S., Zhang, C.Y. & Lowell, B.B. The mitochondrial uncoupling-protein homologues. Nat. Rev. Mol. Cell Biol. 6, 248-261 (2005).
32. Brookes, P.S. Mitochondrial H(+) leak and ROS generation: an odd couple. Free Radic. Biol. Med. 38, 12-23 (2005).
33. Horvath, T.L. et al. Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease. Endocrinology 144, 2757-2760 (2003).
34. Andrews, Z.B. et al. Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease. J. Neurosci. 25, 184-191 (2005).
35. Roffler-Tarlov, S. & Graybiel, A.M. Weaver mutation has differential effects on the dopamine-containing innervation of the limbic and nonlimbic striatum. Nature 307, 62-66 (1984).
36. Ballanyi, K. Protective role of neuronal KATP channels in brain hypoxia. J. Exp. Biol. 207, 3201-3212 (2004).
37. Yamada, K. et al. Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science 292, 1543-1546 (2001).
38. Hernandez-Sanchez, C. et al. Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death. Proc. Natl. Acad. Sci. USA 198, 3549-3554 (2001).
39. Zingman, L.V. et al. Kir6.2 is required for adaptation to stress. Proc. Natl. Acad. Sci. USA 99, 13278-13283 (2002).
40. Patil, N. et al. A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat. Genet. 11, 126-129 (1995).
41. Liss, B. & Roeper, J. Molecular physiology of neuronal K-ATP channels. Mol. Membr. Biol. 18, 117-127 (2001).
42. Conti, B. et al. Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicity. J. Neurochem. 93, 493-501 (2005).
43. Salthun-Lassalle, B., Hirsch, E.C., Wolfart, J., Ruberg, M. & Michel, P.P. Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J. Neurosci. 24, 5922-5930 (2004).
44. Zhou, Q.Y. & Palmiter, R.D. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83, 1197-1209 (1995).
45. O'Rahilly, S., Barroso, I. & Wareham, N.J. Genetic factors in type 2 diabetes: the end of the beginning? Science 307, 370-373 (2005).
46. Craft, S. & Watson, G.S. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. 3, 169-178 (2004).
47. Keuker, J.I., Vollmann-Honsdorf, G.K. & Fuchs, E. How to use the optical fractionator: an example based on the estimation of neurons in the hippocampal CA1 and CA3 regions of tree shrews. Brain Res. Brain Res. Protoc. 7, 211-221 (2001).
48. Alburges, M.E., Narang, N. & Wamsley, J.K. Alterations in the dopaminergic receptor system after chronic administration of cocaine. Synapse 14, 314-323 (1993).
49. Liss, B. et al. Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription. EMBO J. 20, 5715-5724 (2001).